Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP184361.RA769rn8rr43wUZg1WXTZwORCPmaPbmq62HQZULZw3pm4130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP184361.RA769rn8rr43wUZg1WXTZwORCPmaPbmq62HQZULZw3pm4130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP184361.RA769rn8rr43wUZg1WXTZwORCPmaPbmq62HQZULZw3pm4130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP184361.RA769rn8rr43wUZg1WXTZwORCPmaPbmq62HQZULZw3pm4130_provenance.
- NP184361.RA769rn8rr43wUZg1WXTZwORCPmaPbmq62HQZULZw3pm4130_assertion description "[Our results suggest that TOPK is a potential therapeutic target in lung cancer that promotes cell migration by modulating a PI3K/PTEN/AKT-dependent signaling pathway; they also suggest that high TOPK expression, either alone or in combination with a low level of PTEN, may serve as a prognostic marker for lung cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP184361.RA769rn8rr43wUZg1WXTZwORCPmaPbmq62HQZULZw3pm4130_provenance.
- NP184361.RA769rn8rr43wUZg1WXTZwORCPmaPbmq62HQZULZw3pm4130_assertion evidence source_evidence_literature NP184361.RA769rn8rr43wUZg1WXTZwORCPmaPbmq62HQZULZw3pm4130_provenance.
- NP184361.RA769rn8rr43wUZg1WXTZwORCPmaPbmq62HQZULZw3pm4130_assertion SIO_000772 21996732 NP184361.RA769rn8rr43wUZg1WXTZwORCPmaPbmq62HQZULZw3pm4130_provenance.
- NP184361.RA769rn8rr43wUZg1WXTZwORCPmaPbmq62HQZULZw3pm4130_assertion wasDerivedFrom befree-20140225 NP184361.RA769rn8rr43wUZg1WXTZwORCPmaPbmq62HQZULZw3pm4130_provenance.
- NP184361.RA769rn8rr43wUZg1WXTZwORCPmaPbmq62HQZULZw3pm4130_assertion wasGeneratedBy ECO_0000203 NP184361.RA769rn8rr43wUZg1WXTZwORCPmaPbmq62HQZULZw3pm4130_provenance.
- befree-20140225 importedOn "2014-02-25" NP184361.RA769rn8rr43wUZg1WXTZwORCPmaPbmq62HQZULZw3pm4130_provenance.